Eton Pharma Gains FDA Clearance for First Liquid Desmopressin Formulation
Eton Pharma gains FDA approval for DESMODA, the first liquid desmopressin formulation for central diabetes insipidus, launching March 9 with projected peak sales of $30-50 million.
ETONFDA approvalrare disease